Can Fite BioPharma【CANF】株式ニュース

名称	銘柄コード	市場	種別
Can Fite BioPharma Ltd	CANF	AMEX	普通株式

	前日比	前日比 %	現在値	時刻
	0.09	4.43%	2.12	08:59:56

始値	安値	高値	終値	前日終値
2.03	2.00	2.27	2.09	2.03

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/4/25	20:00	BW	Long-term Complete Response to Can-Fite's Namodenoson in..
2024/4/15	20:00	BW	Can-Fite: Scientific Article Published by KOL Presents..
2024/4/03	20:00	BW	Can-Fite: Submits FDA with an IND Application to Conduct..
2024/3/28	20:00	BW	Can-Fite Reports 2023 Financial Results and Clinical Update
2024/3/11	20:27	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/3/11	20:00	BW	Namodenoson Treatment for Pancreatic and Liver Cancer: Data..
2024/2/28	21:06	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/28	21:00	BW	Can-Fite Broadens its Strong Intellectual Property (IP) for..
2024/2/15	05:32	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/1/30	21:24	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/30	21:00	BW	Can-Fite Expands the Out-Licensing Deal with Ewopharma to..
2024/1/29	21:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/29	21:00	BW	Can-Fite: Top Scientific Journal Published Positive Data..
2024/1/08	14:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2023/12/29	06:16	EDGAR2	Form F-3/A - Registration statement by foreign private..
2023/12/20	21:09	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/20	21:00	BW	The Anti-Obesity Effect of Can-Fite’s Namodenoson: Molecular..
2023/12/18	21:07	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/18	21:00	BW	Can-Fite Received FDA Positive Response to Psoriasis..
2023/12/13	06:15	EDGAR2	Form F-3 - Registration statement by foreign private issuers
2023/12/04	21:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/04	21:00	BW	Can-Fite’s Namodenoson for the Treatment of Pancreatic..
2023/11/30	21:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/30	21:00	BW	Can-Fite Reports Third Quarter 2023 Financial Results and..
2023/11/23	06:20	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/11/23	06:15	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/22	06:30	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/22	03:53	GLOBE	Can-Fite Announces Exercise of Warrants for Approximately..
2023/11/21	21:03	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/21	21:00	BW	Can-Fite: Complete Response and 6.9 Years Overall Survival..
2023/11/01	20:05	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/01	20:00	BW	Can-Fite Issues Business Update: All Clinical Programs and..
2023/10/30	20:03	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/30	20:00	BW	Can Fite: Namodenoson Inhibits Pancreatic Carcinoma..
2023/10/26	20:11	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/26	20:00	BW	Can-Fite to Harness Artificial Intelligence to Develop Novel..
2023/10/10	20:01	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/09	20:00	BW	Can-Fite to Share its Rare Genetic Disease Lowe Syndrome..
2023/9/27	20:03	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/27	20:00	BW	Can-Fite Novel Approach for the Treatment of Pancreatic..
2023/9/07	20:25	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/07	20:00	BW	Can-Fite to Share with Investors Latest Oncology and Rare..
2023/9/02	05:16	EDGAR2	Form POS AM - Post-Effective amendments for registration..
2023/9/02	05:15	EDGAR2	Form F-3 - Registration statement by foreign private issuers
2023/8/31	20:12	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/31	20:00	BW	Can-Fite Reports Second Quarter 2023 Financial Results &..
2023/8/24	20:19	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/24	20:10	BW	Can-Fite Enters Rare Genetic Disease Field Based on..
2023/8/18	20:06	EDGAR2	Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/18	20:00	BW	Can-Fite Submitted to FDA a Pediatric Plan to Allow..

この銘柄に関するニュースをもっと見る »

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

CANF Can Fite BioPharma Ltd

最新ニュース

チャート - 1日

チャート - 1年

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Can Fite BioPharma Ltd (CANF) ニュース

CANF Can Fite BioPharma Ltd

最新ニュース

チャート - 1日

チャート - 1年

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手